and society as a whole for improving health care. The committee does not imply that insurers should foot the entire costs for experimental or investigational therapy, but that they should work with the medical scientific community to determine what works and what does not.

To facilitate cooperation to uncover new knowledge about human disease and improve health care, the committee recommends the formation of an alliance that will bring all parties with a vested interest to the table in support of patient-oriented clinical research. New paradigms of cooperation are warranted to continue to improve the health of the U.S. public.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement